Why Screen for Loa Loa Before Filariasis Treatment?
At a Glance
Doctors delay filariasis treatment to test for Loa loa parasites because taking fast-acting medications with a high Loa loa infection can trigger severe, life-threatening brain swelling. Testing ensures your treatment is effective and completely safe.
In this answer
3 sections
When you are diagnosed with lymphatic filariasis or onchocerciasis (river blindness), you might expect to start medication right away. However, your doctor may delay your treatment to first test your blood for another parasite called Loa loa (often known as the African eye worm). It is completely normal to feel anxious about delaying your care, but this short wait is a vital safety precaution and will not worsen your long-term filariasis prognosis.
Taking fast-acting filariasis medications while having a high number of Loa loa parasites in your blood can trigger a severe immune response, leading to a life-threatening condition called encephalopathy (brain inflammation) [1][2].
The Danger of Fast-Acting Medications
Standard treatments for filariasis conditions often include fast-acting anti-parasitic drugs like diethylcarbamazine (DEC) or ivermectin [3][4]. These drugs are highly effective because they rapidly clear out the microscopic young worms (microfilariae) circulating in your bloodstream.
If you have spent time in Central or West Africa, you may have been exposed to Loa loa through the bites of infected deer flies (Chrysops) [5]. Many people with Loa loa have no obvious symptoms—so you might have a high parasite load without ever seeing an “eye worm” or having unexplained skin swellings. If fast-acting drugs are given to someone with a very high load of Loa loa in their blood, they will kill millions of Loa loa parasites all at once [1].
What is Encephalopathy?
When a large number of Loa loa parasites die suddenly, their bodies release proteins that strongly activate your immune system. This intense immune reaction causes systemic inflammation that can cross into the brain, leading to Loa loa-associated encephalopathy [1][6].
Encephalopathy is a medical emergency characterized by severe brain swelling and inflammation. Symptoms can include:
- Acute confusion or sudden changes in mental status [7][8]
- Severe headaches [9]
- Loss of motor skills or paralysis [9]
- Coma or stupor [9][1]
Because the risk is tied to how many Loa loa parasites are in your blood, doctors use a threshold to determine safety. A blood test measures your microfilarial density. While mild adverse reactions can begin when levels exceed 8,000 parasites per milliliter of blood, severe neurological emergencies are strongly linked to counts above 30,000 parasites per milliliter [10][11]. Standard filariasis drugs cannot be safely used if your counts are this high.
How the Screening Works
To ensure your safety, doctors use a “test-and-treat” strategy [12]. This involves checking your blood for Loa loa before giving you any medication. The test might be a traditional blood smear (which can take a few days for a lab to process) or the use of a specialized mobile microscope called a LoaScope. The LoaScope only requires a quick finger prick and can provide results in minutes [12][13].
- If your Loa loa test is negative or very low: Your doctor will likely proceed with standard filariasis medications like DEC or ivermectin [12].
- If your Loa loa test shows high parasite levels: Your doctor has alternative options. Instead of fast-acting drugs, they may prescribe slower-acting medications, such as albendazole [5][14]. This treatment takes several weeks to gently and safely reduce the parasite load over time. Only after the load is lowered can you safely switch to the stronger medicines. In extremely rare, high-risk cases, treatments might be paired with procedures to manually filter the parasites from your blood (apheresis) [7][8].
Waiting for test results when you want to start treating your filariasis can feel frustrating. However, this simple screening is a crucial step that ensures your treatment heals you safely, avoiding severe neurological complications.
Common questions in this guide
Why do I need a Loa loa test before starting filariasis treatment?
What happens if my Loa loa test comes back positive with a high parasite count?
How long does the Loa loa blood test take?
What is Loa loa-associated encephalopathy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How long will my Loa loa test results take to come back?
- 2.What was my exact Loa loa microfilarial density count, and is it considered high risk?
- 3.If I test positive for high Loa loa, what alternative treatment plan will we use to slowly clear the parasites?
- 4.What symptoms should I look out for while I wait to start my filariasis treatment?
- 5.Should I be watching for any specific neurological symptoms, like headache or confusion, once I do start my medication?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Encephalopathy in a patient with loiasis treated with albendazole: A case report.
Volpicelli L, De Angelis M, Morano A, et al.
Parasitology international 2020; (75()):102006 doi:10.1016/j.parint.2019.102006.
PMID: 31676328 - 2
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting.
Burger G, Adamou R, Kreuzmair R, et al.
PLoS neglected tropical diseases 2024; (18(5)):e0012203 doi:10.1371/journal.pntd.0012203.
PMID: 38771861 - 3
Activity of antifilarial drugs on microfilaremia in the treatment of loiasis: a systematic review.
Michelitsch P, Matthies L, Nordmann T, et al.
Parasites & vectors 2025; doi:10.1186/s13071-025-07189-w.
PMID: 41372923 - 4
Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London.
Saito M, Armstrong M, Boadi S, et al.
The American journal of tropical medicine and hygiene 2015; (93(3)):607-11 doi:10.4269/ajtmh.15-0214.
PMID: 26101271 - 5
Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
Pion SDS, Chesnais CB, Weil GJ, et al.
The Lancet. Infectious diseases 2017; (17(7)):763-769 doi:10.1016/S1473-3099(17)30175-5.
PMID: 28372977 - 6
Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Wanji S, Eyong EJ, Tendongfor N, et al.
PLoS neglected tropical diseases 2017; (11(7)):e0005576 doi:10.1371/journal.pntd.0005576.
PMID: 28686693 - 7
Therapeutic apheresis using a mononuclear cell program to lower the microfilaria burden of a 23-year-old African woman with loiasis.
Zhao Y, Alexander B, Bailey JA, et al.
Journal of clinical apheresis 2017; (32(3)):200-202 doi:10.1002/jca.21479.
PMID: 27302472 - 8
Albendazole-related Loa Loa encephalopathy.
Métais A, Michalak S, Rousseau A
IDCases 2021; (23()):e01033 doi:10.1016/j.idcr.2020.e01033.
PMID: 33489754 - 9
Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.
Nzolo D, Anto F, Hailemariam S, et al.
Drugs - real world outcomes 2017; (4(3)):151-158 doi:10.1007/s40801-017-0110-0.
PMID: 28600751 - 10
Safety and effectiveness of apheresis in the treatment of infectious diseases: A systematic review.
Odedra A, Lalloo DG, Kennedy G, et al.
The Journal of infection 2019; (79(6)):513-520 doi:10.1016/j.jinf.2019.09.014.
PMID: 31622632 - 11
Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa.
Chesnais CB, Pion SD, Boullé C, et al.
EClinicalMedicine 2020; (28()):100582 doi:10.1016/j.eclinm.2020.100582.
PMID: 33294807 - 12
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J, Pion SD, Chesnais CB, et al.
The New England journal of medicine 2017; (377(21)):2044-2052 doi:10.1056/NEJMoa1705026.
PMID: 29116890 - 13
Colorimetric and Real-Time Loop-Mediated Isothermal Amplification (LAMP) for Detection of Loa loa DNA in Human Blood Samples.
Febrer-Sendra B, Fernández-Soto P, Crego-Vicente B, et al.
Diagnostics (Basel, Switzerland) 2022; (12(5)) doi:10.3390/diagnostics12051079.
PMID: 35626235 - 14
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD, Nana-Djeunga H, Niamsi-Emalio Y, et al.
The Lancet. Infectious diseases 2020; (20(1)):102-109 doi:10.1016/S1473-3099(19)30554-7.
PMID: 31676244
This page provides educational information about Loa loa screening and filariasis treatment safety. Always consult an infectious disease specialist or your healthcare provider before starting or changing parasitic medication.
Get notified when new evidence is published on Filariasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.